Free Trial

Victrex (VCT) Competitors

GBX 960
+12.00 (+1.27%)
(As of 09/17/2024 ET)

VCT vs. JMAT, ELM, ESNT, SCPA, SYNT, TET, ZTF, IOF, WCH, and ITX

Should you be buying Victrex stock or one of its competitors? The main competitors of Victrex include Johnson Matthey (JMAT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Synthomer (SYNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry.

Victrex vs.

Johnson Matthey (LON:JMAT) and Victrex (LON:VCT) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

65.8% of Johnson Matthey shares are owned by institutional investors. Comparatively, 96.2% of Victrex shares are owned by institutional investors. 0.6% of Johnson Matthey shares are owned by company insiders. Comparatively, 1.7% of Victrex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Victrex had 3 more articles in the media than Johnson Matthey. MarketBeat recorded 4 mentions for Victrex and 1 mentions for Johnson Matthey. Victrex's average media sentiment score of 1.32 beat Johnson Matthey's score of 1.02 indicating that Victrex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Johnson Matthey
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Victrex
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Victrex received 22 more outperform votes than Johnson Matthey when rated by MarketBeat users. Likewise, 63.69% of users gave Victrex an outperform vote while only 62.02% of users gave Johnson Matthey an outperform vote.

CompanyUnderperformOutperform
Johnson MattheyOutperform Votes
485
62.02%
Underperform Votes
297
37.98%
VictrexOutperform Votes
507
63.69%
Underperform Votes
289
36.31%

Johnson Matthey has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500.

Johnson Matthey pays an annual dividend of GBX 77 per share and has a dividend yield of 4.8%. Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 6.3%. Johnson Matthey pays out 13,275.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Johnson Matthey currently has a consensus price target of GBX 1,993.33, indicating a potential upside of 23.73%. Victrex has a consensus price target of GBX 1,485, indicating a potential upside of 55.14%. Given Victrex's higher probable upside, analysts plainly believe Victrex is more favorable than Johnson Matthey.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Johnson Matthey
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Victrex
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Johnson Matthey has higher revenue and earnings than Victrex. Victrex is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey£12.84B0.22£108M£0.582,777.59
Victrex£284.10M2.93£30.70M£0.352,734.77

Victrex has a net margin of 10.81% compared to Johnson Matthey's net margin of 0.84%. Victrex's return on equity of 6.36% beat Johnson Matthey's return on equity.

Company Net Margins Return on Equity Return on Assets
Johnson Matthey0.84% 4.39% 3.41%
Victrex 10.81%6.36%6.59%

Summary

Victrex beats Johnson Matthey on 12 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCT vs. The Competition

MetricVictrexSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£833.03M£8.71B£2.81B£1.42B
Dividend Yield6.22%4.02%5.33%11.46%
P/E Ratio2,734.77295.44122.441,603.61
Price / Sales2.93770.69468,615.17173,255.50
Price / Cash34.2118.0223.3333.13
Price / Book1.818.243.472.85
Net Income£30.70M£133.42M£147.39M£153.50M
7 Day Performance0.65%0.91%3.54%7.25%
1 Month Performance-4.28%3.03%1.59%-1.32%
1 Year Performance-34.62%-3.72%19.87%26.79%

Victrex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JMAT
Johnson Matthey
2.2574 of 5 stars
2.26 / 5 stars
GBX 1,591
+0.3%
GBX 1,993.33
+25.3%
-9.3%£2.82B£12.84B2,743.10N/ANews Coverage
Positive News
Gap Up
ELM
Elementis
0.6036 of 5 stars
0.60 / 5 stars
GBX 159.40
+0.6%
GBX 164.25
+3.0%
+37.8%£939.06M£732.20M-3,985.001,281
ESNT
Essentra
2.3876 of 5 stars
2.39 / 5 stars
GBX 165
+1.1%
GBX 252.50
+53.0%
+15.0%£474.74M£309.70M7,980.00350News Coverage
SCPA
Scapa Group
0 of 5 stars
0.00 / 5 stars
GBX 214.50
flat
N/AN/A£402.98M£281.80M-7.321,461
SYNT
Synthomer
2.4858 of 5 stars
2.49 / 5 stars
GBX 214.33
+1.6%
GBX 313.33
+46.2%
+349.9%£350.58M£1.97B-351.364,200Positive News
TET
Treatt
0 of 5 stars
0.00 / 5 stars
GBX 444
-0.2%
GBX 655
+47.5%
-10.4%£269.60M£143.55M2,466.67365Dividend Increase
Gap Down
ZTF
Zotefoams
0 of 5 stars
0.00 / 5 stars
GBX 426.75
-0.8%
N/A+23.9%£207.40M£133.40M2,133.75549Positive News
IOF
Iofina
1.924 of 5 stars
1.92 / 5 stars
GBX 22
+3.5%
GBX 35
+59.1%
-25.1%£42.21M£50.04M733.3395Gap Up
WCH
Wilmcote Holdings plc (WCH.L)
0 of 5 stars
0.00 / 5 stars
GBX 3
flat
N/A+0.0%£20.13MN/A-5.003
ITX
Itaconix
0 of 5 stars
0.00 / 5 stars
GBX 147.50
-1.7%
N/A-16.6%£19.90M£7.87M-1,000.0017

Related Companies and Tools


This page (LON:VCT) was last updated on 9/17/2024 by MarketBeat.com Staff
From Our Partners